Sight Sciences Reports Q3 GAAP EPS of -$0.64, Missing Estimates by $0.52
Sight Sciences (SGHT) reported third-quarter earnings that significantly missed analyst expectations, posting a GAAP earnings per share (EPS) of -$0.64. This result represents a miss of $0.52 compared to consensus estimates. Despite the earnings miss, the company is focusing on clinical data dissemination for its product pipeline. Management highlighted upcoming presentations regarding Launch-HTN and Explore-OSA at major medical conferences, including the American Heart Association Hypertension Scientific Sessions (AHA-HTN) and the American Society of Nephrology (ASN) Kidney Week 2026.
Tickers: $SGHT
Topics: clinical data presentation earnings report GAAP EPS miss